These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2980209)

  • 1. Squamous and glandular differentiation in urothelial bladder carcinomas. Histopathology, histochemistry and immunohistochemical expression of carcinoembryonic antigen.
    López-Beltrán A; Martín J; García J; Toro M
    Histol Histopathol; 1988 Jan; 3(1):63-8. PubMed ID: 2980209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistological investigations of carcinoembryonic antigen (CEA) in urothelial carcinomas.
    Feil G; Wechsel HW; Nelde HJ; Bichler KH
    Anticancer Res; 1999; 19(4A):2591-7. PubMed ID: 10470200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
    Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
    Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
    Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
    Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
    Genega EM; Hutchinson B; Reuter VE; Gaudin PB
    Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry.
    Lopez-Beltran A; Requena MJ; Alvarez-Kindelan J; Quintero A; Blanca A; Montironi R
    J Clin Pathol; 2007 Mar; 60(3):332-5. PubMed ID: 16882698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
    Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
    Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
    Mai KT; Yazdi HM; Farmer J
    Prostate; 2001 May; 47(3):172-82. PubMed ID: 11351346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive micropapillary carcinoma of the urinary bladder: an immunohistochemical study of neoplastic and stromal cells.
    Kuroda N; Tamura M; Ohara M; Hirouchi T; Mizuno K; Miyazaki E
    Int J Urol; 2006 Jul; 13(7):1015-8. PubMed ID: 16882079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of CEA assay in tissue, serum and urine in patients with transitional cell carcinoma of the bladder.
    Alampi G; Ronchi E; Galassi A; Soli M; Botteghi B; Bercovich E
    Arch Anat Cytol Pathol; 1985; 33(4):193-6. PubMed ID: 3904640
    [No Abstract]   [Full Text] [Related]  

  • 12. Carcinoembryonic antigen in cytological specimens of urothelial carcinoma.
    Holmberg V; Wahren B; Esposti PL
    Cytometry; 1984 Jul; 5(4):437-41. PubMed ID: 6380996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood group H antigen in transitional carcinoma of the urinary bladder.
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study].
    Lanzafame S; Puzzo L; Di Naso C; Di Marco G; Ranno S; Minardi G
    Pathologica; 1986; 78(1056):451-8. PubMed ID: 3302887
    [No Abstract]   [Full Text] [Related]  

  • 16. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
    Bkhatta AD; Makhlin NV
    Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
    [No Abstract]   [Full Text] [Related]  

  • 18. [Usefulness of carcinoembryonic antigen in transitional cell carcinoma of the bladder].
    Moreno Sierra J; Ortega MD; Blanco Jimenez E; Maestro de las Casas ML; Delgado Marti JA; Hermida Gutierrez J; Salinas Casado J; Esteban Fuertes M; Resel Estévez L
    Arch Esp Urol; 1994; 47(1):39-42. PubMed ID: 8192496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma.
    Krüger S; Mahnken A; Kausch I; Feller AC
    Eur Urol; 2005 Apr; 47(4):463-7. PubMed ID: 15774242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells.
    Kuncová J; Urban M; Mandys V
    APMIS; 2007 Nov; 115(11):1194-205. PubMed ID: 18092951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.